331 related articles for article (PubMed ID: 26041736)
1. Melanoma-Derived Wnt5a Promotes Local Dendritic-Cell Expression of IDO and Immunotolerance: Opportunities for Pharmacologic Enhancement of Immunotherapy.
Holtzhausen A; Zhao F; Evans KS; Tsutsui M; Orabona C; Tyler DS; Hanks BA
Cancer Immunol Res; 2015 Sep; 3(9):1082-95. PubMed ID: 26041736
[TBL] [Abstract][Full Text] [Related]
2. Paracrine Wnt5a-β-Catenin Signaling Triggers a Metabolic Program that Drives Dendritic Cell Tolerization.
Zhao F; Xiao C; Evans KS; Theivanthiran T; DeVito N; Holtzhausen A; Liu J; Liu X; Boczkowski D; Nair S; Locasale JW; Hanks BA
Immunity; 2018 Jan; 48(1):147-160.e7. PubMed ID: 29343435
[TBL] [Abstract][Full Text] [Related]
3. Plasmacytoid dendritic cells from mouse tumor-draining lymph nodes directly activate mature Tregs via indoleamine 2,3-dioxygenase.
Sharma MD; Baban B; Chandler P; Hou DY; Singh N; Yagita H; Azuma M; Blazar BR; Mellor AL; Munn DH
J Clin Invest; 2007 Sep; 117(9):2570-82. PubMed ID: 17710230
[TBL] [Abstract][Full Text] [Related]
4. Targeted siRNA silencing of indoleamine 2, 3-dioxygenase in antigen-presenting cells using mannose-conjugated liposomes: a novel strategy for treatment of melanoma.
Chen D; Koropatnick J; Jiang N; Zheng X; Zhang X; Wang H; Yuan K; Siu KS; Shunnar A; Way C; Min WP
J Immunother; 2014; 37(2):123-34. PubMed ID: 24509175
[TBL] [Abstract][Full Text] [Related]
5. Neem leaf glycoprotein overcomes indoleamine 2,3 dioxygenase mediated tolerance in dendritic cells by attenuating hyperactive regulatory T cells in cervical cancer stage IIIB patients.
Roy S; Barik S; Banerjee S; Bhuniya A; Pal S; Basu P; Biswas J; Goswami S; Chakraborty T; Bose A; Baral R
Hum Immunol; 2013 Aug; 74(8):1015-23. PubMed ID: 23628394
[TBL] [Abstract][Full Text] [Related]
6. Dendritic cell based antitumor vaccination: impact of functional indoleamine 2,3-dioxygenase expression.
Wobser M; Voigt H; Houben R; Eggert AO; Freiwald M; Kaemmerer U; Kaempgen E; Schrama D; Becker JC
Cancer Immunol Immunother; 2007 Jul; 56(7):1017-24. PubMed ID: 17195079
[TBL] [Abstract][Full Text] [Related]
7. A lactate-SREBP2 signaling axis drives tolerogenic dendritic cell maturation and promotes cancer progression.
Plebanek MP; Xue Y; Nguyen YV; DeVito NC; Wang X; Holtzhausen A; Beasley GM; Theivanthiran B; Hanks BA
Sci Immunol; 2024 May; 9(95):eadi4191. PubMed ID: 38728412
[TBL] [Abstract][Full Text] [Related]
8. T cell regulatory plasmacytoid dendritic cells expressing indoleamine 2,3 dioxygenase.
Kahler DJ; Mellor AL
Handb Exp Pharmacol; 2009; (188):165-96. PubMed ID: 19031026
[TBL] [Abstract][Full Text] [Related]
9. Molecular analysis of melanoma-induced sentinel lymph node immune dysfunction.
Lee JH; Chen Y; Chan JL; Qian YW; Goydos JS
Cancer Immunol Immunother; 2011 May; 60(5):685-92. PubMed ID: 21327637
[TBL] [Abstract][Full Text] [Related]
10. SOCS3 drives proteasomal degradation of indoleamine 2,3-dioxygenase (IDO) and antagonizes IDO-dependent tolerogenesis.
Orabona C; Pallotta MT; Volpi C; Fallarino F; Vacca C; Bianchi R; Belladonna ML; Fioretti MC; Grohmann U; Puccetti P
Proc Natl Acad Sci U S A; 2008 Dec; 105(52):20828-33. PubMed ID: 19088199
[TBL] [Abstract][Full Text] [Related]
11. Wnt-β-Catenin Signaling in Human Dendritic Cells Mediates Regulatory T-Cell Responses to Fungi via the PD-L1 Pathway.
Karnam A; Bonam SR; Rambabu N; Wong SSW; Aimanianda V; Bayry J
mBio; 2021 Dec; 12(6):e0282421. PubMed ID: 34781737
[TBL] [Abstract][Full Text] [Related]
12. Gut CD103+ dendritic cells express indoleamine 2,3-dioxygenase which influences T regulatory/T effector cell balance and oral tolerance induction.
Matteoli G; Mazzini E; Iliev ID; Mileti E; Fallarino F; Puccetti P; Chieppa M; Rescigno M
Gut; 2010 May; 59(5):595-604. PubMed ID: 20427394
[TBL] [Abstract][Full Text] [Related]
13. Constitutive expression of IDO by dendritic cells of mesenteric lymph nodes: functional involvement of the CTLA-4/B7 and CCL22/CCR4 interactions.
Onodera T; Jang MH; Guo Z; Yamasaki M; Hirata T; Bai Z; Tsuji NM; Nagakubo D; Yoshie O; Sakaguchi S; Takikawa O; Miyasaka M
J Immunol; 2009 Nov; 183(9):5608-14. PubMed ID: 19843945
[TBL] [Abstract][Full Text] [Related]
14. Activation of the Regulatory T-Cell/Indoleamine 2,3-Dioxygenase Axis Reduces Vascular Inflammation and Atherosclerosis in Hyperlipidemic Mice.
Forteza MJ; Polyzos KA; Baumgartner R; Suur BE; Mussbacher M; Johansson DK; Hermansson A; Hansson GK; Ketelhuth DFJ
Front Immunol; 2018; 9():950. PubMed ID: 29867939
[TBL] [Abstract][Full Text] [Related]
15. Indoleamine 2,3-dioxygenase-expressing mature human monocyte-derived dendritic cells expand potent autologous regulatory T cells.
Chung DJ; Rossi M; Romano E; Ghith J; Yuan J; Munn DH; Young JW
Blood; 2009 Jul; 114(3):555-63. PubMed ID: 19465693
[TBL] [Abstract][Full Text] [Related]
16. Wnt5a skews dendritic cell differentiation to an unconventional phenotype with tolerogenic features.
Valencia J; Hernández-López C; Martínez VG; Hidalgo L; Zapata AG; Vicente Á; Varas A; Sacedón R
J Immunol; 2011 Oct; 187(8):4129-39. PubMed ID: 21918189
[TBL] [Abstract][Full Text] [Related]
17. Type III TGF-β receptor downregulation generates an immunotolerant tumor microenvironment.
Hanks BA; Holtzhausen A; Evans KS; Jamieson R; Gimpel P; Campbell OM; Hector-Greene M; Sun L; Tewari A; George A; Starr M; Nixon AB; Augustine C; Beasley G; Tyler DS; Osada T; Morse MA; Ling L; Lyerly HK; Blobe GC
J Clin Invest; 2013 Sep; 123(9):3925-40. PubMed ID: 23925295
[TBL] [Abstract][Full Text] [Related]
18. Human CD14+ CTLA-4+ regulatory dendritic cells suppress T-cell response by cytotoxic T-lymphocyte antigen-4-dependent IL-10 and indoleamine-2,3-dioxygenase production in hepatocellular carcinoma.
Han Y; Chen Z; Yang Y; Jiang Z; Gu Y; Liu Y; Lin C; Pan Z; Yu Y; Jiang M; Zhou W; Cao X
Hepatology; 2014 Feb; 59(2):567-79. PubMed ID: 23960017
[TBL] [Abstract][Full Text] [Related]
19. Indoleamine 2,3-dioxygenase is a critical resistance mechanism in antitumor T cell immunotherapy targeting CTLA-4.
Holmgaard RB; Zamarin D; Munn DH; Wolchok JD; Allison JP
J Exp Med; 2013 Jul; 210(7):1389-402. PubMed ID: 23752227
[TBL] [Abstract][Full Text] [Related]
20. Indoleamine 2,3-dioxygenase, a new prognostic marker in sentinel lymph nodes of melanoma patients.
Speeckaert R; Vermaelen K; van Geel N; Autier P; Lambert J; Haspeslagh M; van Gele M; Thielemans K; Neyns B; Roche N; Verbeke N; Deron P; Speeckaert M; Brochez L
Eur J Cancer; 2012 Sep; 48(13):2004-11. PubMed ID: 22033321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
